2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate Summary

Networked: 37 relevant articles (4 outcomes, 13 trials/studies) for this Bio-Agent

Key Diseases for which 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate is Relevant

1. Acute Myeloid Leukemia (Acute Myelogenous Leukemia) : 1 outcome 5 studies in 7 results
   
2. Neoplasms (Cancer) : 1 outcome 4 studies in 16 results
   
3. Multiple Myeloma : 1 outcome in 2 results
   
4. Hepatocellular Carcinoma (Hepatoma) : 1 outcome in 1 result
   
5. Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell) : 1 study in 1 result
   

Drugs Related to 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate

1. aurora kinase (aurora A kinase)
2. Hormones
3. Cytarabine (Cytosar-U)
4. ABT 263
5. Small Interfering RNA (siRNA)
6. Phosphotransferases (Kinase)
7. Histones (Histone)
8. VX680
9. P-Glycoprotein
10. Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)

Therapies Related to 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate

1. Heterologous Transplantation (Xenotransplantation)